csl behring broadmeadows

Visit CSL Behring's newsroom to find recent news releases, archived releases, and media contacts. Help us deliver on our promise to save lives and protect the health of people. They’re at the core of how our employees interact with each other, make decisions and solve problems. Today, Australian Governments continue to choose CSL Behring as Australia’s national plasma fractionator. In addition to manufacturing plasma products from Australia’s plasma, CSL Behring’s facility in Broadmeadows Victoria also provides highly specialised contract plasma fractionation services to other countries in the region: New Zealand, Hong Kong, Malaysia, Singapore and Taiwan. Thank you for your interest in CSL Behring. Vita means life. We leverage our global supply chain to provide Australia’s patients access to additional imported therapies manufactured overseas by CSL Behring from plasma collected in the US and Europe and recombinant therapies to meet the needs of patients with rare and life threating diseases. CSL Behring’s Australian manufacturing site in Broadmeadows, Victoria Since 2010, CSL Behring has invested in three substantial new manufacturing facilities at our Broadmeadows site. Broadmeadows, VIC CSL Behring R&D and Manufacturing phone: +61 3 9246 5200 fax: +61 …

Join us and make history with the brightest, most passionate people from every discipline. Every day at CSL Behring, we work as if someone's life depends on it, because it does. CSL’s strong commitment to living our Values has guided us for many decades.

It's important and so are you. Help us deliver on our promise to save lives and protect the health of people. It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life. Under Australia’s National Blood Agreement, security of supply for a comprehensive range of important plasma products is underpinned by their on-shore manufacture from Australia’s own plasma, which CSL Behring undertakes at our manufacturing facility in Broadmeadows Victoria. Helping our patient communities is part of our corporate responsibility. CSL Behring is Australia’s chosen national plasma fractionator and, under contract to Australia’s National Blood Authority, manufactures a range of life saving plasma-derived therapies for the treatment of the Australian community. Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise. See the research that is done to find out if medical treatments can improve people's health. The range of plasma-derived therapies we manufacture for Australia is the largest manufactured in a single facility globally. Our scientists and researchers are recognized for their contributions to developing breakthrough medicines that have the potential to help millions of patients worldwide. Director, Construction Management in Broadmeadows, Australia With operations in 35+ nations and 20,000 employees worldwide, CSL is driven to develop and deliver a broad range of lifesaving therapies to treat disorders such as hemophilia and primary immune … Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.

In this section, we share stories aimed at providing insight about, and awareness of, the ever-evolving promise of biotechnology. They are: CSL Behring's portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha 1 Antitrypsin Deficiency. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency. Angelika has been with CSL Behring for nearly 20 years and in that time has grown from having no direct reports to leading a large team in our Quality group.

Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise. The Global Leadership Group’s unwavering commitment to patients enables us to deliver on our obligations to all stakeholders. CSL Direct provides a convenient ordering portal for CSL Behring plasma products and vaccines, visit the If you would like more information about CSL Direct, please call CSL customer service at 1800 063 892For any CSL Plasma corporate or donation inquiries, please refer to the Headquartered in Melbourne, Australia, CSL Limited includes: CSL Behring, incorporating CSL Plasma, and Seqirus. It's important and so are you. Vita means life. See How We're Leading the Way We deliver on our promise to patients. Throughout the 100 years since, CSL has continued to deliver on that original vision - to ensure that Australia retains its own secure supply of important biological medicines - researched, developed and manufactured onshore in Australia, to meet Australia’s requirements. We are also the chosen national plasma fractionator of New Zealand, Hong Kong, Malaysia, Singapore and Taiwan.

We have grown to become one of Australia’s largest public companies, an ‘ASX Top 10’ company that continues to invest in onshore Australian manufacturing operations, and one of the largest biopharmaceutical companies in the world. CSL was established by Australia’s Government in 1916 to ensure an isolated Australia controlled its own supply of biological medicines, particularly in times of war and global pandemics. Today CSL supplies an expanding portfolio of medicines for use in a range of conditions to people in over 30 countries globally. CSL DIRECT CSL Direct provides a convenient ordering portal for CSL Behring plasma products and vaccines, visit the CSL Direct website. It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life. See the research that is done to find out if medical treatments can improve people's health. We have two locations – our manufacturing site at Broadmeadows and our commercial operations office at the Docklands.